Jieping Hu

613 total citations
38 papers, 431 citations indexed

About

Jieping Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jieping Hu has authored 38 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Jieping Hu's work include Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Jieping Hu is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Prostate Cancer Diagnosis and Treatment (6 papers). Jieping Hu collaborates with scholars based in China, Australia and Singapore. Jieping Hu's co-authors include Ruiyuan Xu, Ju Guo, Bin Fu, Jun Deng, Ning Jiang, Libin Sun, Shimiao Zhu, Zhiqun Shang, Qian Dong and Yuanjie Niu and has published in prestigious journals such as British Journal of Cancer, Gene and Protein Science.

In The Last Decade

Jieping Hu

35 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jieping Hu China 13 230 193 102 73 70 38 431
Jinxian Pu China 15 248 1.1× 164 0.8× 144 1.4× 52 0.7× 60 0.9× 55 512
Boxing Su China 11 191 0.8× 111 0.6× 121 1.2× 56 0.8× 75 1.1× 28 397
Judith Bellemare Canada 13 289 1.3× 95 0.5× 79 0.8× 59 0.8× 120 1.7× 18 594
Isabelle Laverdière Canada 14 208 0.9× 104 0.5× 84 0.8× 31 0.4× 82 1.2× 27 458
Yongchang Lai China 13 277 1.2× 260 1.3× 140 1.4× 40 0.5× 101 1.4× 37 505
Peide Bai China 12 265 1.2× 151 0.8× 237 2.3× 34 0.5× 104 1.5× 31 499
Fangyou Lin China 11 177 0.8× 161 0.8× 101 1.0× 30 0.4× 16 0.2× 25 379
B. Alexander Knight United States 9 317 1.4× 127 0.7× 40 0.4× 126 1.7× 43 0.6× 13 496
Binbin Yin China 10 165 0.7× 72 0.4× 79 0.8× 26 0.4× 50 0.7× 19 337
Munehisa Takashi Japan 11 169 0.7× 102 0.5× 49 0.5× 121 1.7× 59 0.8× 34 356

Countries citing papers authored by Jieping Hu

Since Specialization
Citations

This map shows the geographic impact of Jieping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieping Hu more than expected).

Fields of papers citing papers by Jieping Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieping Hu. The network helps show where Jieping Hu may publish in the future.

Co-authorship network of co-authors of Jieping Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jieping Hu. A scholar is included among the top collaborators of Jieping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieping Hu. Jieping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Zengyun, et al.. (2025). Absence of independent prognostic impact of node status in M1 prostate cancer: implications from a SEER-based study. International Urology and Nephrology. 58(2). 537–543.
2.
Hu, Jieping, et al.. (2024). The Prognostic Role of Lymph Node Dissection for High-Risk Localized Prostate Cancer Patients: A Population-Based, Retrospective Cohort Study. Indian Journal of Surgery. 87(S1). 82–89. 1 indexed citations
3.
Hu, Jieping, et al.. (2024). Dexamethasone inhibits androgen receptor-negative prostate cancer cell proliferation via the GR-FOXO3a-GAS5 axis. Heliyon. 10(6). e27568–e27568. 2 indexed citations
4.
Hu, Jieping, et al.. (2024). Analysis of biopsy pathology and risk factors of lymph node metastasis in prostate cancer. International Urology and Nephrology. 56(7). 2261–2267. 1 indexed citations
5.
Hu, Jieping, et al.. (2023). The Changes in Gleason Score Between the Diagnostic Biopsy and Radical Prostatectomy Pathology. Indian Journal of Surgery. 86(2). 361–367. 2 indexed citations
6.
Kang, Seungha, Jieping Hu, Amy L. Hamilton, et al.. (2023). P925 Deep functional assessment of the colonic mucosa-associated microbiota in Crohn’s disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study. Journal of Crohn s and Colitis. 17(Supplement_1). i1035–i1035. 1 indexed citations
7.
Hu, Jieping, et al.. (2022). CT‐Based Predictor for the Success of 12/14‐Fr Ureteral Access Sheath Placement. International Journal of Clinical Practice. 2022(1). 3343244–3343244. 2 indexed citations
8.
Hu, Jieping, et al.. (2022). Identification of the Risk Factors for the Failure of Ureteral Access Sheath Placement. International Journal of Clinical Practice. 2022(1). 7518971–7518971. 8 indexed citations
9.
Tang, Xingming, Wei Zheng, Jieping Hu, et al.. (2022). Proteomics-based analysis of potential therapeutic targets in patients with peritoneal dialysis-associated peritonitis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1870(7). 140796–140796.
10.
Chen, Yujun, Wei Liu, Jieping Hu, et al.. (2021). Fibrin gel‐assisted stone extraction in retrograde intrarenal surgery. British Journal of Urology. 129(2). 170–173.
11.
Hu, Jieping, et al.. (2021). Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration. Cancer Cell International. 21(1). 235–235. 9 indexed citations
12.
Hu, Jieping, et al.. (2020). LncRNA GAS5 participates in the regulation of dexamethasone on androgen receptor -negative and -positive prostate cancer cell proliferation. Molecular and Cellular Probes. 53. 101607–101607. 10 indexed citations
13.
Xu, Ruiyuan & Jieping Hu. (2019). The role of JNK in prostate cancer progression and therapeutic strategies. Biomedicine & Pharmacotherapy. 121. 109679–109679. 72 indexed citations
14.
Ren, Wenbiao, et al.. (2019). Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management. Clinical & Translational Oncology. 22(5). 725–733. 8 indexed citations
15.
Hu, Jieping, et al.. (2019). Ureteral involvement by metastatic malignant disease. Clinical & Experimental Metastasis. 36(6). 499–509. 7 indexed citations
16.
Deng, Wen, Xiaoqiang Liu, Jieping Hu, Luyao Chen, & Bin Fu. (2018). Off-clamp partial nephrectomy has a positive impact on short- and long-term renal function: a systematic review and meta-analysis. BMC Nephrology. 19(1). 188–188. 19 indexed citations
17.
Guo, Ju, et al.. (2018). Androgen Receptor Is Inactivated and Degraded in Bladder Cancer Cells by Phenyl Glucosamine via miR-449a Restoration. Medical Science Monitor. 24. 2294–2301. 8 indexed citations
18.
Hu, Jieping, Jing Tian, Shimiao Zhu, et al.. (2017). Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression. British Journal of Cancer. 118(1). 88–97. 61 indexed citations
19.
Hu, Jieping, Shimiao Zhu, Libin Sun, et al.. (2015). Catalase C-262T polymorphism and risk of prostate cancer: Evidence from meta-analysis. Gene. 558(2). 265–270. 15 indexed citations
20.
Chen, Xu, Jueheng Wu, Zhenjian He, et al.. (2010). Approaches to efficient production of recombinant angiogenesis inhibitor rhVEGI‐192 and characterization of its structure and antiangiogenic function. Protein Science. 19(3). 449–457. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinxian Pu Breakdown of academic impact, for papers by Boxing Su Breakdown of academic impact, for papers by Judith Bellemare Breakdown of academic impact, for papers by Isabelle Laverdière Breakdown of academic impact, for papers by Yongchang Lai Breakdown of academic impact, for papers by Peide Bai Breakdown of academic impact, for papers by Fangyou Lin Breakdown of academic impact, for papers by B. Alexander Knight Breakdown of academic impact, for papers by Binbin Yin Breakdown of academic impact, for papers by Munehisa Takashi
Rankless by CCL
2026